Literature DB >> 26339393

Compromised natural killer cells in pulmonary embolism.

Xiaoyu Zhang1, Qiang Wang2, Yuqin Shen2, Haoming Song2, Zhu Gong2, Lemin Wang2.   

Abstract

OBJECTIVE: The high morbidity, mortality and misdiagnosis rate render pulmonary embolism (PE) as a worldwide health problem. However, the etiology and pathogenesis of this disease have not been well characterized. Increasing studies indicate infection and immunity play a crucial role in PE. Natural killer (NK) cells act as a bridge between the innate immune and acquired immune. This study aimed to investigate the possible function of NK cells in PE.
METHODS: Human cDNA microarray analysis was employed to detect genes associated with NK cells in peripheral blood mononuclear cells (PBMCs). Random variance model corrected t-test was used for statistical analysis of differential gene expression. Flow cytometry was performed to detect the CD16+CD56+ NK cells.
RESULTS: In the present study, based on gene expression microarray analysis, we showed four inhibitory receptors (KLRB1, KLRD1, KLRF1, KLRG1) and four activating receptors (KLRC1, KLRC3, KLRK1 and NCR1) on NK cells were remarkably down-regulated and the cytological experiment demonstrated the proportion of CD16+CD56+ NK cells among PBMCs decreased in the PE group.
CONCLUSIONS: We confirmed the presence of reduced expression of critical activating as well as inhibitory NK cell receptors and low proportion of CD16+CD56+ NK cells in PE. The consistence between genomic and cytological examination suggests compromised NK cells may contribute to the pathogenesis of PE.

Entities:  

Keywords:  Pulmonary embolism; gene; natural killer cell

Mesh:

Substances:

Year:  2015        PMID: 26339393      PMCID: PMC4555721     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  20 in total

1.  Acute pulmonary embolism and dysfunction of CD3+ CD8+ T cell immunity.

Authors:  Lemin Wang; Haoming Song; Zhu Gong; Qianglin Duan; Aibin Liang
Journal:  Am J Respir Crit Care Med       Date:  2011-12-01       Impact factor: 21.405

2.  Low gene expression levels of activating receptors of natural killer cells (NKG2E and CD94) in patients with fulminant type 1 diabetes.

Authors:  Shinsuke Nakata; Akihisa Imagawa; Yugo Miyata; Atsushi Yoshikawa; Junji Kozawa; Kohei Okita; Tohru Funahashi; Seiji Nakamura; Kenichi Matsubara; Hiromi Iwahashi; Iichiro Shimomura
Journal:  Immunol Lett       Date:  2013-10-25       Impact factor: 3.685

3.  Prevention and treatment of venous thromboembolism: international consensus statement (guidelines according to scientific evidence).

Authors: 
Journal:  Clin Appl Thromb Hemost       Date:  2013 Mar-Apr       Impact factor: 2.389

Review 4.  Thrombosis associated with acute cytomegalovirus infection: a meta-analysis.

Authors:  Dan Justo; Talya Finn; Lihi Atzmony; Noam Guy; Arie Steinvil
Journal:  Eur J Intern Med       Date:  2010-12-16       Impact factor: 4.487

5.  Influenza A virus infection and pulmonary microthromboembolism.

Authors:  T Ohrui; H Takahashi; S Ebihara; T Matsui; K Nakayama; H Sasaki
Journal:  Tohoku J Exp Med       Date:  2000-09       Impact factor: 1.848

6.  Association of influenza vaccination with reduced risk of venous thromboembolism.

Authors:  Tienan Zhu; Laure Carcaillon; Isabelle Martinez; Jean-Pierre Cambou; Xavier Kyndt; Karine Guillot; Marie-Christine Vergnes; Pierre-Yves Scarabin; Joseph Emmerich
Journal:  Thromb Haemost       Date:  2009-12       Impact factor: 5.249

7.  Herpes simplex virus infection, massive pulmonary thromboembolism, and right atrial thrombi in a single patient: case report.

Authors:  Asli Görek; Sule Akçay; Oya Altas Ibiş; Ilyas Atar; Füsun Oner Eyüboğlu
Journal:  Heart Lung       Date:  2007 Mar-Apr       Impact factor: 2.210

8.  Acute infections and venous thromboembolism.

Authors:  M Schmidt; E Horvath-Puho; R W Thomsen; L Smeeth; H T Sørensen
Journal:  J Intern Med       Date:  2011-12-08       Impact factor: 8.989

9.  HIV-Associated Venous Thromboembolism.

Authors:  Michele Bibas; Gianluigi Biava; Andrea Antinori
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-07-08       Impact factor: 2.576

10.  Characteristics of the complement system gene expression deficiency in patients with symptomatic pulmonary embolism.

Authors:  Wei Lv; Lemin Wang; Qianglin Duan; Zhu Gong; Fan Yang; Haoming Song; Yanli Song
Journal:  Thromb Res       Date:  2013-05-30       Impact factor: 3.944

View more
  2 in total

1.  An interaction map of circulating metabolites, immune gene networks, and their genetic regulation.

Authors:  Artika P Nath; Scott C Ritchie; Sean G Byars; Liam G Fearnley; Aki S Havulinna; Anni Joensuu; Antti J Kangas; Pasi Soininen; Annika Wennerström; Lili Milani; Andres Metspalu; Satu Männistö; Peter Würtz; Johannes Kettunen; Emma Raitoharju; Mika Kähönen; Markus Juonala; Aarno Palotie; Mika Ala-Korpela; Samuli Ripatti; Terho Lehtimäki; Gad Abraham; Olli Raitakari; Veikko Salomaa; Markus Perola; Michael Inouye
Journal:  Genome Biol       Date:  2017-08-01       Impact factor: 13.583

2.  The role of bone marrow-derived cells in venous thromboembolism.

Authors:  Joana Campos; Alexander Brill
Journal:  Int J Biochem Cell Biol       Date:  2020-09-17       Impact factor: 5.085

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.